CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (CAPITAL DEFICIENCY) - USD ($) $ in Thousands		Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2015		$ 10,873	$ 100	$ 194,064	$ (183,291)
Balance (in shares) at Dec. 31, 2015	[1]		99,800,397
Share-based compensation related to stock options		327		327
Share-based compensation related to restricted stock award		48		48
Share-based compensation related to restricted stock award (in shares)	[1]		7,843
Net loss from continuing operations		(8,526)			(8,526)
Net loss from discontinued operations		(72)			(72)
Balance at Mar. 31, 2016		2,650	$ 100	194,439	(191,889)
Balance (in shares) at Mar. 31, 2016	[1]		99,808,240
Balance at Dec. 31, 2016		(9,957)	$ 124	202,575	(212,656)
Balance (in shares) at Dec. 31, 2016	[1]		124,134,085
Share-based compensation related to stock options		118		118
Share-based compensation related to restricted stock award
Convertible notes conversions (in shares)	[1]		923,018
Convertible notes conversions		517	$ 1	516
Net loss from continuing operations		(59,148)			(59,148)
Net loss from discontinued operations		0
Balance at Mar. 31, 2017		$ (68,470)	$ 125	$ 203,209	$ (271,804)
Balance (in shares) at Mar. 31, 2017	[1]		125,057,103

[1] Common Stock, $0.001 par value; Authorized – as of March 31, 2017 and 2016 - 250,000,000 and 150,000,000 shares, respectively.